血红蛋白、碱性磷酸酶和C反应蛋白可预测脂肪肉瘤患者的预后。
Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.
作者信息
Panotopoulos Joannis, Posch Florian, Alici Benjamin, Funovics Philipp, Stihsen Christoph, Amann Gabriele, Brodowicz Thomas, Windhager Reinhard, Ay Cihan
机构信息
Department of Orthopaedics, Medical University of Vienna, Vienna, Austria.
出版信息
J Orthop Res. 2015 May;33(5):765-70. doi: 10.1002/jor.22827. Epub 2015 Mar 13.
Data on prognostic biomarkers in soft tissue sarcomas are scarce. The aim of the study was to define prognostic markers in patients with a liposarcoma, a subtype of sarcoma derived from adipose tissue. We restrospectively reviewed 85 patients with liposarcoma treated at our department from May 1994 to October 2011. Kaplan-Meier curves, uni-, and multivariable Cox proportional hazard models and competing risk analysis were performed to evaluate the association between putative biomarkers with disease-specific and overall survival. We observed a significant association between both alkalic phosphatase (ALP; subhazard ratio [SHR] per 1 unit increase: 1.35; 95%CI 1.10-1.65; p = 0.005) and C-reactive protein (CRP; SHR per 1 mg/dl increase: 2,57; 95%CI 1.36-4,86; p = 0.004) with disease-specific survival. Hemoglobin (Hb) (HR per 1 g/dl increase: 065; 95%CI 0.48-0.87; p = 0.003) was associated with overall survival. These associations prevailed after multivariable adjustment for AJCC tumor stage. This study identifies CRP and ALP as novel independent predictors of disease-specific survival in patients with liposarcoma.
关于软组织肉瘤预后生物标志物的数据很少。本研究的目的是确定脂肪肉瘤(一种源自脂肪组织的肉瘤亚型)患者的预后标志物。我们回顾性分析了1994年5月至2011年10月在我科接受治疗的85例脂肪肉瘤患者。采用Kaplan-Meier曲线、单变量和多变量Cox比例风险模型以及竞争风险分析来评估假定生物标志物与疾病特异性生存和总生存之间的关联。我们观察到碱性磷酸酶(ALP;每增加1个单位的亚风险比[SHR]:1.35;95%CI 1.10-1.65;p = 0.005)和C反应蛋白(CRP;每增加1mg/dl的SHR:2.57;95%CI 1.36-4.86;p = 0.004)与疾病特异性生存均存在显著关联。血红蛋白(Hb)(每增加1g/dl的HR:0.65;95%CI 0.48-0.87;p = 0.003)与总生存相关。在对AJCC肿瘤分期进行多变量调整后,这些关联仍然存在。本研究确定CRP和ALP为脂肪肉瘤患者疾病特异性生存的新的独立预测因子。